Powering Drug Discovery via Research Intelligence

Translation of biomedical research from the bench to the bedside is a key focus for any research group involved in drug discovery and development. Considering the huge capital expenditure in healthcare research, it is prudent to streamline one’s research workflow to avoid costly failures in later stages. This can be done using trusted and reliable data to make the right Go/No Go decisions at every stage of development.

With high quality, rigorously curated scientific information that offers billions of hard data points, the Cortellis™ platform can help identify emerging and current research trends in biomedical sciences, understand the molecular mechanism of disease, identify targets, benchmark experimental compounds, engage with relevant external experts, and monitor competitor activity.

Being able to do these tasks efficiently and effectively with reliable and trustworthy information will accelerate any institutional drug development program, reduce drugs failure rates, and keep it one step ahead of competition.

This is a two-part webinar series which provides a glimpse into the literature and in-silico tools from Clarivate that aid drug discovery and research.

 

Additional note:

  • A certificate of participation will be provided for those who have attended both the webinars
  • Each webinar is of 60 min. duration.

 

Schedule

Schedule:

  • Session 1 | Tuesday, 17 May 2022 at 11:00 AM IST/1:30 PM SGT/3:30 PM AEST
  • Session 2 | Thursday, 19 May 2022 at 11:00 AM IST/1:30 PM SGT/3:30 PM AEST

Speaker

Featured Speaker:
Dr. Subhasree Nag
Regional Solutions Consultant
Clarivate

Dr. Subhasree Nag is a regional solutions consultant for the life sciences and scholarly research division at Clarivate. She completed her PhD from Texas Tech University Health Sciences Center, USA and her post-doctoral training from Pacific Northwest National Laboratory, USA. A pharmacologist and toxicologist by training, she has more than 8 years of research experience in anticancer drug discovery, preclinical pharmacology, and systems biology areas with 25 peer reviewed publications and more than 700 citations.

Topics

Topics that will be covered:

- Understanding the Molecular Mechanisms of Disease and Target Identification
- Target Prioritization and Benchmarking Lead Candidates